|
Rituximab
Product Approval Information - Licensing Action
Proper name: Rituximab
Tradename: Rituxan
Manufacturer: IDEC Pharmaceutical Corp, San Diego, CA, License #1235
Indication for Use: Revise the dosage and administration section of the package insert to include information regarding the use of Rituximab as a component of the Zevalin therapeutic regimen
Approval Date: 2/19/2002
Type of submission: Biologics license application supplement
Approval Letter
(Text)
Label
(Part 1),
(Part 2)
Last Updated: 3/5/2002
Back
to Top
Back to Index
Updated: September 25, 2003 |
|